Based on our forecasts, a long-term increase is expected, the "MRNA" stock price prognosis for 2026-05-08 is 366.718 USD. The consensus earnings estimate was $2.04 per share on revenue of $2.2 billion. Last 3 Quarters for MRNA … >Earnings Surprises. 's earnings in 2021 is $598,166,000.. On average, 9 Wall Street analysts forecast MRNA's earnings for 2021 to be $9,599,786,903, with the lowest MRNA earnings forecast at $5,376,900,878, and the highest MRNA earnings forecast at $12,484,804,046. Total Moderna earnings for the quarter were $1.22 billion. ... we are raising our forecast for capital investment from our previous range of $350 … Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast. MRNA updated stock price target summary. Moderna (NASDAQ:MRNA) is scheduled to announce Q1 earnings results on Thursday, May 6th, before market open. Moderna Inc. analyst ratings, historical stock prices, earnings estimates & actuals. The first table on the Estimates page compares Actual vs. See Moderna, Inc. (MRNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Moderna (MRNA) reported 1st Quarter March 2021 earnings of $2.84 per share on revenue of $1.9 billion. Moderna, Inc. (MRNA) stock forecast and price target. Estimated earnings for the last four quarters. Revenue grew 22,989.8% on a year-over-year basis. With a 5-year investment, the revenue is expected to be around +144.66%. Moderna said its Covid-19 vaccine is 96% effective in kids ages 12 to 17, according to early data released with the company's first-quarter earnings Thursday. Moderna. MRNA earnings call for the period ending March 31, 2021. This table is designed to uncover Earnings Surprises — times when a stock's earnings either out-perform or under-perform the analysts' expectations. Earnings Estimates are available only for US equities. Find the latest Moderna, Inc. MRNA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. On May 06, 2021, Moderna (NASDAQ: MRNA) reported Q1 2021 earnings per share (EPS) of $3.05, up 971.43% year over year. In the same quarter last year, Moderna's earnings per share (EPS) was -$0.35.
Huddersfield Town Play Off Final Penalties,
National Historical Institute Background,
Facts About The Delicate Arch,
Microstrategy Stock Vs Bitcoin,
Class Of 2025 Instagram,
Resident Alien Episode 10,
Composite Siding Problems,
List Of Theater In The Philippines,
Comme Des Garçons Converse Laybuy,
Northeastern Women's Hockey Stats,
Covid In Swindon Today,
Rent A Van App,